Stereotactic Ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34880
Abstract: BACKGROUND During coronavirus disease 2019 (COVID-19)-related operating room closures, some multidisciplinary thoracic oncology teams adopted a paradigm of stereotactic ablative radiotherapy (SABR) as a bridge to surgery, an approach called SABR-BRIDGE. This study presents the… read more here.
Keywords: sabr; sabr bridge; stereotactic ablative; ablative radiotherapy ... See more keywords
Volumetric modulated arc therapy (VMAT) comparison to 3D‐conformal technique in lung stereotactic ablative radiotherapy (SABR)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Radiation Sciences"
DOI: 10.1002/jmrs.634
Abstract: Stereotactic ablative radiotherapy (SABR) can be a curative option for non‐small cell lung cancer (NSCLC) and oligometastatic lung disease. Volumetric modulated arc therapy (VMAT) has offered further advancements in terms of radiation dose shaping without… read more here.
Keywords: sabr; stereotactic ablative; ablative radiotherapy; radiotherapy ... See more keywords
Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the Literature
Sign Up to like & getrecommendations! Published in 2019 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2018.10.002
Abstract: Abstract Stereotactic ablative radiotherapy as a treatment option for stage I neuroendocrine cancer of the lung is not yet well understood. While analogs can be made to non-small cell lung cancer, high-grade neuroendocrine tumors are… read more here.
Keywords: neuroendocrine cancer; cancer lung; ablative radiotherapy; cancer ... See more keywords
Stereotactic Ablative Radiotherapy Versus Surgery in Early Lung Cancer: A Meta-Analysis of Propensity Score-Adjusted Comparative Effectiveness Studies
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Radiation Oncology Biology Physics"
DOI: 10.1016/j.ijrobp.2017.06.1668
Abstract: Objectives: Stereotactic ablative radiotherapy (SABR) represents an alternate modality to surgery in early-stage non-small cell lung cancer (ES-NSCLC). No completed randomized controlled trial (RCT) comparing these treatments in operable patients is available. Propensity score (PS)-adjusted… read more here.
Keywords: surgery; analysis; ablative radiotherapy; stereotactic ablative ... See more keywords
Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches.
Sign Up to like & getrecommendations! Published in 2018 at "Lung cancer"
DOI: 10.1016/j.lungcan.2018.07.002
Abstract: The use of stereotactic ablative radiotherapy (SABR) for central lung tumors is increasing. Centrally located lung tumors can be subdivided into two categories, namely the 'moderately central' tumors where the planning target volume is located… read more here.
Keywords: lung tumors; ablative radiotherapy; stereotactic ablative; radiotherapy sabr ... See more keywords
Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
Sign Up to like & getrecommendations! Published in 2018 at "Japanese Journal of Clinical Oncology"
DOI: 10.1093/jjco/hyy062
Abstract: Split-course stereotactic ablative radiotherapy (SABR) appeared to achieve favorable toxicity profiles and local control outcomes comparable with those of continuous SABR in the patients with oligometastases. read more here.
Keywords: ablative radiotherapy; stereotactic ablative; course stereotactic; split course ... See more keywords
Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis
Sign Up to like & getrecommendations! Published in 2021 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.13768
Abstract: Stereotactic ablative radiotherapy (SABR) is the current standard‐of‐care in cases of inoperable early stage non‐small cell lung cancer (ES‐NSCLC). This study aimed to assess the survival outcomes and recurrence patterns after SABR for ES‐NSCLC in… read more here.
Keywords: non small; stage non; ablative radiotherapy; early stage ... See more keywords
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.20.00818
Abstract: PURPOSE The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data that test… read more here.
Keywords: stereotactic ablative; term; arm; long term ... See more keywords
Cost-effectiveness analysis of stereotactic ablative radiotherapy in patients with oligometastatic cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.7085
Abstract: 7085Background: The SABR-COMET randomized clinical trial found that stereotactic ablative radiotherapy (SABR) improved outcomes among cancer patients with oligometastatic disease. Yet, the cost of ... read more here.
Keywords: ablative radiotherapy; cancer; stereotactic ablative; cost effectiveness ... See more keywords
Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.22727
Abstract: Stereotactic ablative radiotherapy (SABR) is the main treatment for inoperable early-stage non-small cell lung cancer (NSCLC). Despite the widespread use of SABR, the biological determinants of response to SABR remain poorly investigated. We developed an… read more here.
Keywords: response; ablative radiotherapy; cancer; stereotactic ablative ... See more keywords
What is the role of stereotactic ablative radiotherapy in the management of surgically resectable and operable stage I non-small cell lung cancer?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2017.03.57
Abstract: The use of stereotactic ablative radiotherapy (SABR) with the intention to cure stage I non-small cell lung cancer (NSCLC) in preference to surgical resection is currently a contentious and hotly debated topic. It may even… read more here.
Keywords: management; ablative radiotherapy; lung cancer; stereotactic ablative ... See more keywords